Le lancement en Chine se précise - ACHAT - OC 9€ (vs 8,6€)
Après l’annonce de la création d’une co-entreprise avec Furui en Chine, nous avançons le lancement commercial de l’Echopulse sur ce marché à 2017 (vs 2018 préc.). Cette co-entreprise, dans laquelle Theraclion détiendra 56% des parts, permet à la société de garder le contrôle tout en s’associant avec un acteur local réputé. Le marché chinois est gigantesque, les remboursements des traitements HIFU sont déjà présents et les avantages de l’Echopulse y sont particulièrement adaptés. Après mise à jour de notre modèle de valorisation par DCF et des paramètres de marché, nous relevons légèrement notre objectif à 9€ vs 8,6€ préc. Opinion ACHAT renouvelée.Theraclion SA. Theraclion is a France-based company, which develops High Intensity Focused Ultrasound (HiFu) machines. The Company is a a spin-off of Inserm and EDAPTechomed. The main activity of the Company is developping, manufacturing and marketing echotherapy medical equipments associating therapy by focused ultrasound and monitoring by ultrasound. The Company provides Echopulse, a device for the non-invasive and outpatient treatment of the fibroadenoma of the breast and thyroid nodules.
Since 2006, Invest Securities has become one of the leading players in investment services for funds and managers, to whom we offer a global and personalised service. Our track record differentiates us and proves our leadership in numerous promising sectors like property and growth companies.
Consisting of 13 different profiles (pharmacist, engineer, financier, etc), the DNA of our financial analysis office is value added and sector expertise. Through daily monitoring and detailed analyses of companies and sectors, we seek to provide a differentiating vision of our 120 stocks followed. Our ideas are circulated every day to nearly 1,000 professionals.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.